Onkos Surgical to Distribute OsteoCrete Bone Void Filler

Bone Solutions Osteocrete

Bone Solutions (BSI) announced a private label licensing agreement whereby Onkos Surgical will distribute and market OsteoCrete® magnesium-based bone void filler under the GenVie™ brand, for use in certain tumor and complex revision cases.

FDA has cleared OsteoCrete for use in bone-related surgical procedures ranging from complex...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us